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Minikel et al., page 371
Recent evidence has suggested the existence of anticipa-
tion in familial Creutzfeldt-Jakob disease (CJD), such that
onset of CJD in affected children occurs 7–14 years earlier
than it did in their parents. Like that of many Mendelian
disorders, the cause of CJD (a dominant mutation in
PRNP) was only identified in the last 25 years. However,
the mechanism of anticipation was unclear because CJD
does not share the characteristics that cause anticipation
in other disorders, such as expansion-repeat diseases.
Now, through extensive analysis, Minikel et al. demon-
strate that the evidence for anticipation in CJD is most
likely due to ascertainment bias introduced in the analysis
by the short window in which individuals with PRNP
mutations were ascertained. When the authors looked in
this timeframe, they found that pairs of children who
died earlier than their parents, as well as individuals who
were born later but reached the age of onset in the time-
frame, were enriched in the ascertainment window. More-
over, when individuals with deaths from other causes were
included, the anticipation was still observed, suggesting
that the anticipation reported in hereditary CJD is an arti-
fact. Accordingly, the evidence of anticipation disappeared
when the window was corrected for. Because the problem
of ascertainment bias might also apply to many recently
identified Mendelian disorders, several approaches should
be used so these biases can be avoided. Studies should
provide the year of onset or death for all individuals, test
for a correlation between year of birth and age of onset,
and test to determine whether these families show evi-
dence of anticipation in deaths from other causes.Identifying Convergent Adaptation
Foll et al., page 394
Previous studies have attempted to determine whether
populations under the same environmental conditions
have adapted to the environment in similar ways, i.e.,
via convergent evolution. Many times, these analyses are
a post hoc comparison of the overlap in signals identified
in the distinct populations because it can be difficult
to compare multiple populations with varying allele fre-
quencies and demographic histories at the same time.
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regions. In this study, Foll et al. used a flexible hierarchical
Bayesian approach that allowed them to search for signals
of adaptation to high altitude in both Tibetan and Andean
populations simultaneously. With this increase in power,
the authors not only confirm previous reports of selection
in EGLN1 but also suggest that, like in Tibetans, EPAS1
might be under selection in Andeans and provide evidence
of convergent selection in additional genes and pathways,
such as genes involved in alcohol and fatty-acid meta-
bolism and genes potentially involved in responsiveness
to neuronal excitotoxicity. Interestingly, the identified sig-
nals suggest that convergent adaptation is more common
than previously recognized. As this approach is applied
to previous work, it will be interesting to see whether
existing data yield previously unrecognized convergent
adaptation.Consequences of Gene Conversion
Lachance et al., page 408
Gene conversion can occur during recombination; sub-
sequent DNA mismatch repair corrects the mismatch
between the alleles. However, the mismatch-repair ma-
chinery preferentially retains guanine and cytosine bases
rather than adenine and thymine, leading to a bias
in gene conversion, called GC-biased gene conversion
(gBGC). This can have effects on allele frequency and
linkage disequilibrium, but the effect at the population
level has been unclear. In this study, Lachance et al. used
high-coverage whole-genome sequencing from 25 indi-
viduals representing five populations to identify signals
of gBGC. It appears that the strength of gBGC is on par
with weak selection, in which evolutionary rates are
increased at sites favoring the derived allele and decreased
at sites favoring the ancestral allele. This finding has impli-
cations for human disease because many deleterious alleles
are derived alleles rather than ancestral alleles. Individuals
from bottlenecked populations, such as Europeans and
Hadza, have a higher frequency of homozygous derived
alleles than do nonbottlenecked populations, such as
Pygmy, Yoruba, and Sandawe. However, the strength,
and therefore the effect on disease burden, is mitigated
in genomic regions under strong selection, in which the
equilibrium in allele frequency is balanced between selec-
tion and mutation rather than gBGC and mutation. Takeny of Human Genetics. All rights reserved.
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together, these results suggest that gBGC has implications
for human disease and that incorporating the effects of
gBGC into models of evolution could improve accuracy.
A Clearer View of Genetic Variation
Fu et al., page 421
Demographic changes, coupled with mutational forces,
have shaped human history in ways we are only now
beginning to understand. A key set of questions, the
answers to which require both theoretical and empirical
studies, relates to the accumulation of deleterious alleles
in human populations. Where and when did deleterious
alleles arise, what influence have these mutations had
in the past, and how do they continue to affect human
health and disease? Although many studies have begun
to address these questions, the results have, at times,
been less than clear. Now, in a study utilizing data from
the Exome Sequencing Project, Fu et al. provide new in-
sights into the complex interplay between demography
and natural selection both within and between popu-
lations. The authors demonstrate that differences in
analytical approach—for instance, whether the focus is
on individuals or populations—can lead to disparate inter-
pretations of the same data. This work represents a clear
step forward in our understanding of human genetic vari-
ation and the forces that shaped it, but the authors rightly
caution that much more work is needed before we can use
this type of genetic data in the clinical realm.342 The American Journal of Human Genetics 95, 341–342, OctoberUncovering Cryptic Chromosomal Changes
Brand et al., page 454
The introduction of chromosomal microarray (CMA) to
the clinic made possible the molecular diagnosis of a spec-
trum of disorders, underscoring the contribution of struc-
tural variation to human disease. The limitations inherent
in this technology, however, make it impossible to detect
very small copy-number variants and balanced chromo-
somal translocations. Investigators have begun to explore
the ability to detect these types of chromosomal abnor-
malities through other means, including whole-genome
sequencing. In this issue, Brand et al. report on their use
of so-called jumping libraries to uncover a range of chro-
mosomal variations in children with neuropsychiatric
disorders. The authors identified variation that would be
detectable by CMA or karyotyping, as well as numerous
variants whose detection is refractory to those approaches.
Indeed, up to 80% of the identified variants would have
beenmissed by CMA alone. Interpretation of the identified
variants yielded clear insights into the phenotypes of the
affected individuals, demonstrating that this approach,
with time and cost estimates roughly equivalent to those
of CMA, holds great promise for clinical application.
Although larger cohorts will need to be evaluated, this
work, in conjunction with projects aimed at cataloguing
single-nucleotide variants, represents an important step
toward delineating the landscape of variation present in
neuropsychiatric disorders.2, 2014
